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The final proof for the correctness of the present view that  experimental 
renal hypertension is caused by a humoral mechanism of renal origin would be 
the demonstration  of the presence of a  pressor substance of renal  origin  in 
the circulating systemic blood of animals with persistent hypertension of this 
type.  The proof thXt essential human hypertension is of similar  origin would 
be the demonstration of the corresponding substance in the blood of human 
beings with this type of hypertension. 
Although there are many reasons for assuming that in vivo the proteolytic 
action of the enzyme renin on a pseudoglobulin (hypertensinogen) in the plasma 
results in the formation of the vasoconstrictor substance hypertensin, a poly- 
peptide, nevertheless the final proof for the existence  of this humoral mecha- 
nism  in  the  circulating  systemic  blood  of  animals  with persistent, benign, 
experimental renal hypertension has been lacking until now, and some investi- 
gators have asserted that in the later stages a neurogenic factor is responsible 
for the persistence of the elevated blood pressure.  The present publication 
deals with the demonstration and identification of a pressor substance (hyper- 
tensin) in the systemic blood of animals in the earlier period of experimental 
renal hypertension. 
The development of the method for the detection of hypertensin in the blood 
was based on the finding  of Bean (1) that the enzyme hypertensinase, which 
destroys hypertensin, is almost without activity at 0°C.  By the elimination 
of hypertensinase activity immediately after the withdrawal of the systemic 
blood, and the immediate separation and precipitation of the plasma, it should 
be possible to detect any hypertemsin  present in the circulating blood at the 
time the specimen of blood is withdrawn.  Furthermore,  it has been shown 
by Sapirstein and collaborators (2) that at 0°C. renin continues to act on renin 
substrate, although at a diminished rate, and that the reaction reaches equilib- 
rium in about 2 hours.  Thus, by prolonged incubation of the plasma, in the 
cold, the action of a small amount of renin on the renin substrate in the blood 
can be enhanced, in vitro, and the presence of renin  detected without the ad- 
dition of renin substrate. 
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Method 
With 50 cc. syringes containing heparin so!ution, 200 cc. of blood was drawn rapidly from 
the jugular vein or femoral artery of a dog weighing 12 to I5 kilos.  An 18 gauge needle was 
used,  so  that  the  withdrawal  of  the  entire  amount  was  completed  in  less  than  5 
minutes.  Every syringeful of blood was immediately chilled by being emptied into a 250 cc. 
centrifuge cup standing in an acetone and dry ice bath, at  -20°C.  During the process of 
cooling, the blood was stirred constantly by a bent glass rod attached to an air-driven stirrer. 
When the entire amount of blood had been put into the centrifuge cup~ no more dry ice was 
added to the bath, the temperature of which was usually about -  I0°C. when that of the blood 
was about 5°C.  The entire 200 cc. of blood was cooled to 0°C. in not more than 10 minutes. 
The moment the blood had reached 0°C., the stirring was stopped and the centrifuge bottle 
containing the blood was removed instantly from the ice bath in order to avoid freezing of the 
blood.  The blood was then centrifuged at 0°C. for 30 minutes at 15,000 Ra,.M. in a brine- 
cooled centrifuge.  After eentrifugation the plasma usually had a temperature of about 7°C. 
The plasma, which was not hemolyzed, if freezing had been avoided, was drawn off by means 
of a previously cooled syringe, transferred to a cooled 250 cc. centrifuge bottle, and left stand- 
ing in a cooler at 0°C. for 24 hours.  Two hours at O°C.  was the minimum incubation time for 
the optimum yield of hypertensin.  At the end of that time the plasma was transferred to a 
250 ce. beaker previously cooled in a  deep freezer at -20°C.  The beaker was placed in a 
dish containing a  dry ice and acetone mixture at -10°C.  The pH of the plasma was now 
adjusted to 4.5 with 10 N HC1 solution by use of glass electrodes.  About one-fourth of the 
cold plasma was poured into another 250 cc. beaker previously heated in a  bath of boiling 
water.  The plasma was  stirred constantly while it was being coagulated,  and,  when the 
temperature had reached 70°C., another fourth of the cold plasma was added.  The heating 
was continued until the temperature of the plasma had reached at least 90°C.  In this way 
the hypertensinase  of the first fourth of the plasma acted at body temperature for a  very 
short time.  At pH 4.5 a clear supernatant fluid resulted after heat coagulation of the plasma 
proteins.  This liquid was filtered off with suction through  a  small Biichner funnel.  The 
pH of the clear filtrate was usually about 5.5 and was then adjusted to 7.4 with N/10 NaOH 
solution.  The final volume, approximately one-fourth of the original amount of blood, or 
about 50 per cent of the plasma, was cooled to body temperature and injected intravenously 
into a trained unanesthetized dog.  A 100 cc. syringe and an 18 gauge needle were used for 
the injection, which lasted approximately 30 seconds. 
EXPERIMENTS 
The Demonstration of Hypertensin  in the Systemic Blood of Normal Dogs after 
the Intravenous Injection  of Various Quantities of Renin.--It was demonstrated 
first  that  the  intravenous  injection  of  the  solution  prepared  in  the  manner 
described above from a  large quantity of the serum of an animal with normal 
blood  pressure  has  no  pressor  effect.  As  a  control  of  the  experiments  sum- 
marized in Table II, samples of 200 cc. of systemic blood of normal dogs that 
had not received an intravenous injection of renin were treated by the method 
described above and tested for the presence of renin and hypertensin.  Table I 
shows  that  the  plasma  from  this  quantity  of  blood  of normal  dogs  did  not 
contain or develop a  pressor substance in an amount detectable by the method 
used. 
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blood can be detected.  Since it is assumed that renin is the substance which 
initiates  the  humoral  mechanism  of  experimental  renal  hypertension,  the 
attempt was made to learn whether the result of the interaction of renin and 
renin substrate  (hypertensinogen) in vivo, as well as in vitro,  is hypertensin, 
which can be recovered from the circulating blood.  For this purpose various 
quantities of standardized renin  (3),  of known potency, were  injected into 
normal dogs, and the withdrawal of 200 cc. of venous blood was begun at the 
height of the rise of blood pressure, 2 to 3 minutes after the injection of the 
renin was completed.  The blood was then treated in the manner described 
above for the demonstration of hypertensin.  To demonstrate existent hyper- 
tensin, some of the specimens were coagulated by heat immediately after the 
separation of the plasma.  In order to determine how much hypertensin would 
be formed by the amount of renin and hypertensinogen present in the sample, 
TABLE I 
Hypertensin in Systemic Blood of Normal Dogs 
Plasma from 200 co. of blood  Rise in bloodpressure 
Dog. No.  (incubation at 0°C.).  (direct mean femoral) 
8-43 
10-49 
10-48 
10-47 
10-45 
10-48 
hf$. 
24 hrs. 
cg  ~¢ 
o 
o 
o 
o 
o 
o 
other specimens were allowed to stand at 0°C. for 24 hours before they were 
coagulated.  The results obtained from the intravenous injection of 1 to 50 
units of renin are shown in Table II.  They confirm the finding of Houssay, 
Braun-Menendez, and Dexter (3 a)  that intravenously injected renin can be 
detected in the systemic blood. 
Table II shows that immediately after the intravenous injection of renin 
a  non-protein,  heat-stabile,  vasopressor  substance  is  rapidly formed,  which 
can be isolated from the plasma, and which, when injected intravenously into 
a normal dog, produces a type of rise of blood pressure which is characteristic 
of hypertensin, dz. an immediate rise, which reaches a maximum in 1 minute 
or less, and is of short duration, 3 minutes or less.  Thus, it has been shown that 
the result of the action of renin on the substrate in the plasma in eivo is the 
same as that which occurs in dlro  (4).  Table II shows that the amount of 
hypertensin found in the plasma during the first 5 minutes after the injection 
of renin increases with the amount of renin injected into the blood and that 
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of renin are injected.  Even  after the intravenous injection of only 1 unit of 
renin there is some formation of hypertensin,  mounting  to  as much  as half 
a unit in 200 cc. of blood, if the plasma is coagulated immediately after separa- 
TABLE II 
Units of renin  Plasma from 200 co.  Rise in blood 
Dog No.  Weight  injected  of blood  pressure (direct 
intravenously  (kept at O°C.)  mean femoral) 
8-72 
10-44 
9-33 
10-24 
10-40 
9-32 
10-62 
9-32 
10-35 
10-14 
9-32 
10-14 
10-41 
10-14 
8-48 
8-43 
8-82 
10-10 
10-29 
9-43 
10-27 
9-95 
3-31 
10-10 
9-87 
9-32 
10-19 
9-43 
10-36 
Ibs. 
39 
22 
36 
29 
19 
47 
30 
47 
26 
27 
47 
27 
23 
27 
23 
40 
29 
42 
30 
19 
28 
32 
48 
42 
20 
33 
47 
25 
31 
5 
5 
5 
5 
5 
5 
5 
10 
10 
10 
10 
10 
20 
20 
20 
50 
M 
24 hrs. 
cc  ~ 
24 hrs. 
c~  ~ 
24 hrs. 
H. 
0 
0 
15 
15 
10 
0* 
30 
25 
30 
0* 
30 
0* 
30 
10 
40 
10 
30 
40 
5O 
5O 
0* 
30 
0* 
4O 
4O 
30 
3O 
6O 
75 
* These failures to demonstrate any pressor effect, and also the variations, are probably due 
to technical errors, or to destruction of the hypertensin during preparation. 
tion, and about  1 unit if the plasma is kept at 0°C.  for 24 hours before it is 
coagulated by heat. 
The Demonstration of Hypertensin  in the Systemic Blood of Dogs with Benign 
Experimental  Renal Hypertension.--For  this  series of experiments dogs  were 
made hypertensive by constriction of their main renal arteries (5).  In some 
dogs  this  operation  was  performed  unilaterally, but  in most  of  the  animals F.  GOLLAN,  E. RICHAKDSON~  AND  H.  GOLDBLATT  393 
both renal arteries were constricted and, after the blood pressure had risen to 
a hypertensive level, blood was withdrawn from"  the jugular vein and treated 
in the manner described above for the demonstration of hypertensin. 
TABLE III 
(a) Hypertensin in plasma of dogs with  experimental  hypertension after unilateral damping of the main 
renal artery. 
Dog No. 
10.30 
10-39 
10-24 
10-39 
Weight 
20 
30 
29 
30 
Period of 
hypertension 
days 
3 
4 
11 
20 
Blood 
pressure 
M.  Hg. 
175 
180 
165 
185 
Amount 
of blood 
190 
4O0 
4O0 
400* 
Incubation 
at 0°C." 
24 hrs. 
Rist in blood 
pressure 
mm. 
0 
25 
30 
o~ 
(b) Hypertensin in plasma of dogs with experimental  h3fpertension after bilateral  clamping  of the main 
renal arteries. 
Period of  Blood  Amount  Incubation Rise in blood 
Dog. No.  Weight  hypertension  pressure  of blood  at O°C.  pressure 
10-45 
10.39 
10-27 
10-40 
10-30 
10.30 
10-47 
9-22 
10-29 
10-29 
10-29 
8-67 
4-61 
lbs. 
23 
30 
26 
22 
20 
20 
28 
24 
33 
33 
33 
38 
37 
2 days 
3  tt 
5  ct 
11  " 
19  " 
23  " 
25  " 
79  " 
89  " 
3 mos. 
18  " 
3 yrs. 
I.Hs 
125 
190 
140 
140 
190 
180 
175 
200 
190 
190 
190 
190 
200 
300 
70 
225 
300 
450 
330 
360 
4OO 
200 
200 
52O 
200 
200 
24 hrs. 
g¢  ~g 
gg  gg 
24  " 
¢t  t¢ 
mm. 
15 
5 
25 
0 
15 
4O 
30 
0 
10 
0 
20 
15 
0 
* The plasma  filtrate,  after precipitation,  was concentrated  to 17 cc. by  pervaporation. 
Some of the failures to demonstrate  a pressor effect, and also the variations,  may have 
been  the result of technical  errors  or destruction  of the  hypertensin  during  preparation. 
After unilateral or  bilateral  constriction  of  the  renal  arteries,  the  pressor 
substance was detected in the systemic blood of some of the dogs with experi- 
mental  benign renal  hypertension  that  had  existed  for  as  long  as  3  months 
(see Table III), especiaUy when large amounts of blood were tested. 
The  amount  of blood necessary for the  detection of half to  1  unit  of  the 
pressor  substance  (about  200  cc.)  is  equal  to  about  one-fifth of  the  whole 
blood volume of  the  animal.  In  control tests  it  was  noticed  that  when  an 
unusually  large  amount  (500  cc.)  of  blood  was  drawn  from  single  normal 394  HYPERTENSIN  IN  SYSTEMIC  BLOOD  OF  ANIMALS 
animals,  the plasma  supernatant  (after heat coagulation of the plasma)  also 
gave a shght pressor effect, up to half a  unit of hypertensin in 350 to 500 cc. 
blood.  To eliminate this possibility of misinterpretation of the results, samples 
of not more than 200 cc. of blood were taken from each of several normal and 
hypertensive dogs and pooled.  Each large sample was treated in the manner 
previously described for the demonstration of hypertensin and the final products 
were pooled and concentrated by pervaporation in front of a revolving fan, at 
room temperature, in a  2 inch cellophane tubing, from about 400 cc. to 50 cc. 
or less.  Control tests with known amounts of diluted hypertensin showed that 
by this method of concentration about one-third of the  hypertensin  activity 
is lost. 
TABLE IV 
Hypertensln in Large Pooled Samples of Blood 
Normal dogs 
Amount of pooled  Incubation at O°C.  Treated plasma  Rise in blood pressure 
systemic blood  concentrated to cc.  (direct mean femoral) 
800 
8OO 
7OO 
1500 
24 hrs.  25 
25 
35 
50 
mm. 
o 
o 
o 
o 
Hypertensive dogs 
700  24 hrs.  35  30 
1500  "  "  50  45 
800  72  "  17  30 
Table IV shows  that in  chronic benign experimental hypertension, hypero 
tensin can be demonstrated in the circulating blood, if large amounts of sys- 
temic blood pooled from several animals are used. 
The Demonstration  of Hypertensin in Blood from the Renal  Vein of an Is- 
chemic Kidney.--It has been shown that by the addition of renln substrate to 
the  renal vein blood from an  ischemic kidney,  and  incubation,  hypertensin 
can be demonstrated (6), although none can be detected without the addition 
of the  hypertensinogen.  The addition of the  latter  presumably allows  the 
renin present in the blood to form more hypertensin.  Yet it seemed important 
to demonstrate the formation of hypertensin from the renin and hypertensino- 
gen present in the renal venous blood from an ischemic kidney, by the method 
described in this paper. 
Table V  shows that it was possible to demonstrate the existence of hyper- 
tensin and, by inference, renin, in the renal vein blood from a kidney the renal ]L GOLLAIq,  E. RICHARDSON~  AND  H.  GOLDBLATT  395 
artery of which was constricted.  Renal vein blood from a normal kidney did 
not contain hypertensin. 
In normal dogs, one renal artery was constricted by a  clamp.  After 4  days, when the 
blood pressure had risen 40 to 70 ram. Hg above nornial, the dogs were anesthetized with 
ether and, by retroperitoneal approach, renal vein blood from the normal kidney as well as 
from the kidney with renal artery constricted was taken by separate rapid cannulation of 
both veins.  The bloods were treated in the usual manner, immediately after withdrawal, 
and also after an incubation period of 24 hours at 0°C. 
The Demonstration of Hypertensin in the Systemic Blood of Dogs witk Experi- 
mental Renal Hypertension of the Malignant Type.--Both main renal arteries 
of dogs were constricted so that the malignant type of hypertension (7), with 
renal insufficiency and necrotizing arteriolitis, resulted. 
TABLE  V 
Itypertensin  in Blood flora  Renal  Vein 
h]'ormal renal vein blood. 
[schemic renal vein blood. 
Amount  of blood 
125" 
145" 
20O 
160 
Incubation  of 
plasma  at O°C. 
24 hrs. 
24 hrs. 
Rise in blood 
pressure (direct 
mean femoral) 
mfI~. 
0 
0 
20 
45 
* The amount of normal blood was less, but there was not sufficient difference to account 
for the difference in content of pressor substance. 
Table VI shows that in the malignant phase of experimental renal hyper- 
tension the existence of relatively large amounts of hypertensin in the systemic 
blood can be demonstrated.  In 300 cc. of systemic blood of dog 10-34, weigh- 
hag 20 pounds, 6 units of hypertensin were detected, after incubation for 24 
hours. 
The Effect of Hypertensinase on the Pressor Substance Derived  from the Sys- 
temic Blood of a Normal Dog, after the Intravenous Injection of Renin, and from 
the Systemic Blood of a Dog with Malignant ttypertension.--If  the pressor sub- 
stance present in the blood of animals with experimental renal hypertension 
is really hypertensin, it should be destroyed by hypertensinase. 
Control  experiments  were  performed first,  of  which  the  following  are 
examples, 
Twenty units of hog renin were injected intravenously into a  normal dog, No. 9-43,  and, 
after 2  minutes, 200 cc.  of  blood was withdrawn from the jugular vein.  The blood was 
chilled immediately to 0°C. and centrifuged for 1 hour in the cold.  The plasma was then 
separated and left standing at 0°C., for 24 hours.  The 120 cc. of plasma was then divided 396  HYPERTENSIN  IN  SYSTEMIC BLOOD OF  AXqMALS 
into two equal parts.  The first part was immediately coagulated by heat, after adjustment 
of pH to 4.5.  The second part was first subjected to the action of the hypertensinase in the 
blood by incubation at 40°C. for 24 hours and then also coagulated by heat, after adjustment 
of pH to 4.5.  Both samples were filtered through Btichner filters, and the pit of the filtrates 
was adjusted to 7.2.  Then the solutions were injected into normal dogs to test for the hyper- 
TABLE VI 
Hypertensin in Blood of Dogs with Experimental Malignant  Renal Hypertension  (Both  Renal 
Arteries  Greatly Constricted 
Dog No.  Weight 
lbs. 
10-39  30 
9-98  31 
10-46  29 
10-30"  21 
10-45  23 
10-34  23.5 
Period of  hyper-  Blood 
__tensi°n  .__pressure 
days  ]  ram. 
i  220 
175 
185 
~2  185  2O5 
175 
Amount 
of blood 
vithdrawn 
500 
850 
7O 
190 
300 
290 
In¢ tbation 
~rs. 
24 
Total yield 
of de.pro- 
teh~Lzed 
plasma 
CO. 
2OO 
80 
120 
120 
Amount 
injected 
to test 
for l~res~r 
effect 
G$. 
20 
70 
30 
80 
60 
60 
20 
Rise in blood 
~ressure 
(direct mean 
femoml) 
M. 
25 
30 
15 
0 
40 
50 
30 
* Dog 10-30 was the only one that was not uremic when the sample of blood was taken, 
but that azotemia alone is not accompanied by the accumulation of renin or hypertensin in 
the blood is shown by the absence of a  pressor substance  in the blood of two bilaterally 
nephrectomized  dogs with pronounced  azotemia  (see  below). 
Hypertension in Blood of Bila~ally Nephrectomised Azotemic Dogs 
Period 
after 
Dog. No.  Weight  bilateral  Blood 
nephree-  pressure 
tomy  J 
--  [ -- 
I  lbs"  I  days  I  tara. 
$ 
I0-19~  44  ~  3  125 
10-56~  49  ]  2  125 
I  I  {  Amo-~t 
injected  Amount  ....  lIncu  &tionlb  "  Total...  I tote t  fors 
OI DIOOQ  ylela  pressor 
C~:.  ~P'$.  6G.  CG, 
200  24  90  /  90 
300/  24  I  130  J  130 
Rise  in  blood 
pressure 
(direct mean 
femoral) 
0 
0 
Both dogs had azotemia at the time the sample of blood was withdrawn for detection 
of a pressor substance.  In dog 10-19 the blood urea nitrogen was 192 rag., the creatinine was 
9.5 nag., and the CO2-combining  power was 40.1 volumes per 100 cc., while in dog 10-56 the 
values were blood urea nitrogen 99.8 mg., creatinine 7.2 nag., and CO2 43.5 volumes per 100 cc. 
tensin present.  Part  1 (without hypertensinase  action)  gave a  rise of 60 man. Hg. Part 2 
(with hypertensinase action) gave a rise of 20 ram. Hg. 
The same experiment was repeated.  About 2 minutes after the intravenous injection of 
10 units of hog renin into dog 9-98,  200 co. of blood was withdrawn.  Part 1 (without hyper- 
tensinase action) gave a rise of 35 mm. Hg, Part 2 (with hypertensinase action) gave no rise. 
In another experiment, the plasma from 200 cc. of blood of a dog with malignant hyper- 
tension was treated  in the manner  described  above for the demonstration of hypertensin. 
Of this plasma, 20 cc. gave a rise of 30 mm. Hg when injected intravenously into a normal ~F.  GOLLAN,  E.  RICHARDSON,  AND  H.  GOLDBLATT  397 
dog.  The remaining 50 cc. was divided  into three parts.  One part was incubated at 40°C. 
with 10 cc. of normal dog plasma, containing hypertensinase.  The hypertensin was com- 
pletely inactivated in 1 hour.  A second part was incubated at 40°C., with a  plant hyper- 
tensinase preparation,  (150 units),  derived  from wheat bran  (8), which does not destroy 
adrenalin  or  hydroxytyramine,  but  does  inactivate  hypertensin,  produced  in  ~ilro.  The 
hypertensin was completely inactivated in 1 hour.  The third part was used as control (not 
treated) and gave a rise of 30 ram. Hg. 
These three tests show that the pressor substance which forms in the systemic 
blood after the intravenous injection of renin, or after the constriction of the 
main renal arteries,  is destroyed by hypertensinase.  Since incubation with 
plasma  containing  hypertensinase, or  with  plant  hypertensinase,  destroys 
only hypertensin, and does not affect adrenalin or hydroxytyramine~  the pressor 
substance in the systemic blood of dogs with experimental renal hypertension 
must be hypertensin or some similar substance. 
Chemical Properties of the Pressor Substance in the Systemic Blood of Animals 
with Experimental Renal Hypertension of the Malignant  Type.--Plasma  from 
the systemic blood of dogs with malignant hypertension was used to test for 
some of the chemical properties which characterize known hypertensin.  Dur- 
hag the processing of the plasma the substance was subjected to boiling for 
10 minutes at pH 4.5, and remained active.  Therefore, the substance is heat- 
stabile and acid-fast.  An amount of processed plasma capable  of giving a 
rise of 30 ram. Hg if injected intravenously into an unanesthetized normal dog 
was boiled for 10 minutes at pH  12.5.  After the solution had been  cooled, 
the pH was  adjusted to  7.4 with normal HC1.  This procedure  resulted in 
complete destruction of the pressor activity.  The same mount of processed 
plasma was dialyzed against cold running tap water for 18 hours.  The pressor 
substance  disappeared from the solution in the  tubing.  The same amount 
of processed plasma  was  extracted  three  successive  times with  ether,  in  a 
separatory funnel, but the pressor activity was not affected by this procedure. 
Thus the pressor substance in the circulating systemic blood of dogs with 
the  malignant  type  of  experimental  renal  hypertension  is  a  non-protein 
substance, heat-stabile, dialyzable, acid-fast, alkali-labile and ether-insoluble. 
These qualities are characteristic of hypertensin. 
DISCUSSION 
Many attempts have been made to demonstrate the existence of a pressor 
substance in the systemic blood of hypertensive animals:-- 
Collins and Hoffbauer  (9)  transfused  blood equal to 20 per cent of body weight 
from a hypertensive dog to a normal dog without obtaining an elevation  of blood 
pressure in the recipient dog. 
Katz, Friedman, Rodbard, and Weinstein (10) transfused  up to 2500 cc. of blood 
from a hypertensive dog into a normal dog, by cross-transfusion, without getting a 398  HYPERTENSII~  IN  SYSTEMIC  BLOOD  OF  A~S 
positive result.  Similar experiments,  with negative results, have been performed by 
Honssay and Fasciolo  (ll).  Solandt, Nassim,  and Cowan  (12) transfused up to 3 
liters of blood from hypertensive a  nlmals into normal dogs without producing a rise in 
blood pressure,  but they did observe an elevation of blood pressure  when such large 
amounts of blood were transfused into bilaterally nephrectomized animals. 
Although I. H. Page (13) was unable to show any pressor effect in 50 cc. of blood 
from hypertensive dogs, yet later he was able to detect a vasoconstrictor substance 
in 0.4 cc. of plasma from dogs with experimental renal hypertension, if it was perfused 
through an isolated rabbiUs ear.  There is no proof that this effect was due to hyper- 
tensin and the work has not been confirmed by others (14). 
Heymans and Bouckaert could not demonstrate a pressor substance in up to 20 cc. 
of blood from hypertensive dogs (15), and others (18,  19) have failed  to find  hyper- 
tensin  in  the blood of hypertensive patients  or animals,  or in the blood of animals 
after an intravenous injection of renin. 
The failure of all these attempts to detect the pressor substance in the sys- 
temic blood of dogs with experimental renal hypertension can be explained by 
the inadequate amounts of blood tested and the failure to avoid destruction of 
the  pressor  substance  by  the  action  of  hypertensinase  during  the  tests. 
Dell'Oro and Braun-Menendez  (16)  detected renin in both the renal venous 
blood and in blood from the femoral artery of dogs with experimental renal 
hypertension that had lasted only a few days.  They detected it in as little as 
12 cc. of plasma by adding hypertensinogen to enhance the action of the renin 
and by testing for the hypertensin formed.  On this account,  their estimate 
about  the amount of renin  (100 to  200  units)  constantly circulating in  the 
systemic blood of a dog in the earliest stage of experimental renal hypertension 
is probably too high.  The results of our study show that pressor substance 
is present in small quantity in the  circulating blood;  therefore, even in the 
earliest stage, but especially in the later stage of the benign phase of experi- 
mental renal hypertension, a large amount of blood must be tested if the hyper- 
tensin is to be detected without enhancing the action of renin by the addition 
of hypertensinogen.  This amount corresponds to from one-fifth to one-third 
of the animal's blood.  But even then the pressor substance cannot be demon- 
strated if the action of the hypertensinase of the plasma is not inhibited.  Since 
1 cc. of plasma contains almost 1 unit of hypertensinase (17), the 300 to 400 
units of hypertensinase can quickly destroy the 1 unit of hypertensin present 
in this amount of blood, if no precautions are taken to prevent this reaction. 
If the blood is even slightly hemolyzed, much greater amounts of hypertensinase 
are available for the destruction of the small amount of hypertensin present 
in  the  circulating  systemic blood,  because  red  blood corpuscles  are  rich  in 
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SUMMARY 
I.  A method has been developed which makes possible the demonstration of 
a pressor substance in the circulating systemic blood of dogs with experimental 
renal hypertension. 
2.  Mter the intravenous injection of renin into normal dogs, it was possible 
to  detect a  pressor substance formed  in  the systemic blood.  After the  in- 
travenous injection of 1 unit of renin, as much as 1 unit of the pressor substance 
was detected in the plasma from 200 cc. of systemic blood. 
3.  Large amounts of systemic blood pooled from several normal dogs did 
not contain detectable amounts of pressor substance. 
4.  In  experimental  renal  hypertension  due  to  unilateral  or bilateral  con- 
striction of the main renal arteries,  a pressor substance was demonstrated in 
large amounts of systemic blood, corresponding to from one-fifth  to one-third 
of the total blood volume.  This was accomplished  without the addition of 
hypertensinogen to enhance the action of the renin in the blood.  In an animal 
weighing  about 15 kilos,  with benign hypertension up to 3 months' duration, 
about 3 to 5 units of this pressor substance are probably constantly circulating 
in the entire systemic blood. 
5.  The pressor substance was also detected in a relatively small amount of 
renal vein blood from an ischemic kidney. 
6.  In the systemic blood of dogs weighing  about 15 kilos,  with malignant 
experimental renal hypertension, from 15 to 25 units, or more, of the pressor 
substance are present in the entire  circulating  blood. 
7.  The pressor substance which appears in the systemic blood of dogs with 
experimental renal hypertension, and of nor/hal dogs after intravenous injec- 
tion of renin,  is destroyed by hypertensinase. 
8.  The pressor substance obtained from  the systemic blood of dogs with 
experimental  renal  hypertension  has  the  same  physiological  and  chemical 
properties as hypertensin produced in vitro.  It is therefore suggested that the 
name hypertensin be adopted for the pressor substance which causes experi- 
mental renal hypertension. 
.~..~9. In this study the animals in the benign phase of hypertension were almost 
all in the early stage (3 months or less).  Whether the humoral mechanism 
obtains in animals in the late stage, after years of hypertension, or in any form 
of human hypertension is being investigated. 
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